Pharmacokinetic Analysis of 111In-Labeled Liposomal Doxorubicin in Murine Glioblastoma after Blood-Brain Barrier Disruption by Focused Ultrasound

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Yang, Feng Yi ^a   Wang, Hsin Ell ^a   Liu, Ren Shyan ^a   Teng, Ming Che ^a   Li, Jia Je ^a   Lu, Maggie ^b   Wei, Ming Cheng ^b   Wong, Tai Tong ^c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; INDIUM 111; LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD BRAIN BARRIER; BRAIN TUMOR; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG ACCUMULATION; FOCUSED ULTRASOUND; GLIOBLASTOMA; MALE; MICROSPECTROPHOTOMETRY; MOUSE; NONHUMAN; RADIOACTIVITY; ULTRASOUND;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; BRAIN NEOPLASMS; CELL LINE, TUMOR; DOXORUBICIN; GLIOBLASTOMA; HUMANS; INDIUM RADIOISOTOPES; MALE; MICE; MICE, INBRED NOD; MICE, SCID; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; SONICATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ANIMALIA; MURINAE; MUS;

EID: 84866495183     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045468     Document Type: Article

References (28)

1. Black KL, Ningaraj NS, (2004) Modulation of brain tumor capillaries for enhanced drug delivery selectively to brain tumor. Cancer Control 11: 165-173.
2. Deen DF, Chiarodo A, Grimm EA, Fike JR, Israel MA, et al. (1993) Brain Tumor Working Group Report on the 9th International Conference on Brain Tumor Research and Therapy. Organ System Program, National Cancer Institute. J Neurooncol 16: 243-272.
3. Bakker-Woudenberg IA, Lokerse AF, Roerdink FH, (1989) Antibacterial activity of liposome-entrapped ampicillin in vitro and in vivo in relation to the lipid composition. J Pharmacol Exp Ther 251: 321-327.
4. Messerer CL, Ramsay EC, Waterhouse D, Ng R, Simms EM, et al. (2004) Liposomal irinotecan: formulation development and therapeutic assessment in murine xenograft models of colorectal cancer. Clin Cancer Res 10: 6638-6649.
5. Nacucchio MC, Gatto Bellora MJ, Sordelli DO, D'Aquino M, (1988) Enhanced liposome-mediated antibacterial activity of piperacillin and gentamicin against gram-negative bacilli in vitro. J Microencapsul 5: 303-309.
6. Boerman OC, Storm G, Oyen WJ, van Bloois L, van der Meer JW, et al. (1995) Sterically stabilized liposomes labeled with indium-111 to image focal infection. J Nucl Med 36: 1639-1644.
7. Li SD, Huang L, (2008) Pharmacokinetics and biodistribution of nanoparticles. Mol Pharm 5: 496-504.
8. Papahadjopoulos D, Allen TM, Gabizon A, Mayhew E, Matthay K, et al. (1991) Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci U S A 88: 11460-11464.
9. Farber E, Rubin H, (1991) Cellular adaptation in the origin and development of cancer. Cancer Res 51: 2751-2761.
10. Puri RK, Leland P, Kreitman RJ, Pastan I, (1994) Human neurological cancer cells express interleukin-4 (IL-4) receptors which are targets for the toxic effects of IL4-Pseudomonas exotoxin chimeric protein. Int J Cancer 58: 574-581.
11. Joshi BH, Leland P, Asher A, Prayson RA, Varricchio F, et al. (2001) In situ expression of interleukin-4 (IL-4) receptors in human brain tumors and cytotoxicity of a recombinant IL-4 cytotoxin in primary glioblastoma cell cultures. Cancer Res 61: 8058-8061.
12. Husain SR, Behari N, Kreitman RJ, Pastan I, Puri RK, (1998) Complete regression of established human glioblastoma tumor xenograft by interleukin-4 toxin therapy. Cancer Res 58: 3649-3653.
13. Hong HY, Lee HY, Kwak W, Yoo J, Na MH, et al. (2008) Phage display selection of peptides that home to atherosclerotic plaques: IL-4 receptor as a candidate target in atherosclerosis. J Cell Mol Med 12: 2003-2014.
14. Yang FY, Lin GL, Horng SC, Chang TK, Wu SY, et al. (2011) Pulsed high-intensity focused ultrasound enhances the relative permeability of the blood-tumor barrier in a glioma-bearing rat model. IEEE Trans Ultrason Ferroelectr Freq Control 58: 964-970.
15. Yang FY, Lin YS, Kang KH, Chao TK, (2011) Reversible blood-brain barrier disruption by repeated transcranial focused ultrasound allows enhanced extravasation. J Control Release 150: 111-116.
16. Yang FY, Wang HE, Lin GL, Teng MC, Lin HH, et al. (2011) Micro-SPECT/CT-based pharmacokinetic analysis of 99mTc-diethylenetriaminepentaacetic acid in rats with blood-brain barrier disruption induced by focused ultrasound. J Nucl Med 52: 478-484.
17. Treat LH, McDannold N, Vykhodtseva N, Zhang Y, Tam K, et al. (2007) Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound. Int J Cancer 121: 901-907.
18. Olson RD, Mushlin PS, (1990) Doxorubicin cardiotoxicity: analysis of prevailing hypotheses. FASEB J 4: 3076-3086.
19. Pardridge WM, (2005) The blood-brain barrier: bottleneck in brain drug development. NeuroRx 2: 3-14.
20. van Rooy I, Mastrobattista E, Storm G, Hennink WE, Schiffelers RM, (2011) Comparison of five different targeting ligands to enhance accumulation of liposomes into the brain. J Control Release 150: 30-36.
21. Yuh EL, Shulman SG, Mehta SA, Xie J, Chen L, et al. (2005) Delivery of systemic chemotherapeutic agent to tumors by using focused ultrasound: study in a murine model. Radiology 234: 431-437.
22. Frenkel V, Kimmel E, Iger Y, (2000) Ultrasound-induced intercellular space widening in fish epidermis. Ultrasound Med Biol 26: 473-480.
23. Lee WH, Yeh MY, Tu YC, Han SH, Wang YC, (1988) Establishment and characterization of a malignant glioma cell line, GBM8401/TSGH,NDMC. J Surg Oncol 38: 173-181.
24. Chow TH, Lin YY, Hwang JJ, Wang HE, Tseng YL, et al. (2008) Diagnostic and therapeutic evaluation of 111In-vinorelbine-liposomes in a human colorectal carcinoma HT-29/luc-bearing animal model. Nucl Med Biol 35: 623-634.
25. Chow TH, Lin YY, Hwang JJ, Wang HE, Tseng YL, et al. (2009) Therapeutic efficacy evaluation of 111In-labeled PEGylated liposomal vinorelbine in murine colon carcinoma with multimodalities of molecular imaging. J Nucl Med 50: 2073-2081.
26. Yang FY, Liu SH, Ho FM, Chang CH, (2009) Effect of ultrasound contrast agent dose on the duration of focused-ultrasound-induced blood-brain barrier disruption. J Acoust Soc Am 126: 3344-3349.
27. Yang FY, Horng SC, Lin YS, Kao YH, (2010) Association between contrast-enhanced MR images and blood-brain barrier disruption following transcranial focused ultrasound. J Magn Reson Imaging 32: 593-599.
28. Loening AM, Gambhir SS, (2003) AMIDE: a free software tool for multimodality medical image analysis. Mol Imaging 2: 131-137.